drugset / Trial / NCT05885594

Imaging Inflammation With Alcohol Use Disorder: an [18F]NOS Study

NCT05885594 ↗

Phase 0 Active not recruiting 4 enrolled University of Pennsylvania
Non-randomizedParallel-groupOpen-labelDiagnostic

Summary

Study to enroll up to 90 individuals, those with an alcohol use disorder (AUD) (up to n=60) and non-dependent healthy volunteers (HV) (up to n=30). PET/CT imaging will be used to evaluate brain and whole-body inflammation using the investigational radiotracer \[18F\]NOS. All participants will have one \[18F\]NOS positron emission tomography/ computed tomography (PET/CT) scan performed.

Timeline

Start
2023-08-08
Primary completion
2027-03-15
Completion
2027-03-15

Drugs

EvaluationDrugModalityDoseRoute
Subject [18F]NOS Diagnostic / imaging agent 6.5 unknown —